Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiAntonio

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
JCI Insight|January 4, 2024
Sarm1 knockout prevents type 1 diabetic bone disease in females independent of neuropathyJennifer M Brazill, Ivana R Shen, Clarissa S Craft, et al.
The Journal of Cell Biology|December 22, 2021
Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPNYihang Li, Maria F Pazyra-Murphy, Daina Avizonis, et al.
Clinical Chemistry|February 16, 2017
Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe DiseaseNa Lin, Jingyu Huang, Sara Violante, et al.
Journal of Clinical Immunology|March 1, 2014
Newborn screening for SCID in New York State: experience from the first two yearsBeth H Vogel, Vincent Bonagura, Geoffrey A Weinberg, et al.
Brain : a Journal of Neurology|January 13, 2022
The human cognition-enhancing CORD7 mutation increases active zone number and synaptic releaseMila M Paul, Sven Dannhäuser, Lydia Morris, et al.
The Journal of Biological Chemistry|September 27, 2023
The structure of NAD<sup>+</sup> consuming protein Acinetobacter baumannii TIR domain shows unique kinetics and conformationsErik Klontz, Juliet O Obi, Yajing Wang, et al.
Scientific Reports|March 19, 2016
Clec16a is Critical for Autolysosome Function and Purkinje Cell SurvivalVeronika Redmann, Christopher A Lamb, Seungmin Hwang, et al.
Molecular Neurodegeneration|October 15, 2025
Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapiesEmily L Ward, Larry Benowitz, Thomas M Brunner, et al.
Molecular Cell|March 25, 2022
Structural basis of SARM1 activation, substrate recognition, and inhibition by small moleculesYun Shi, Philip S Kerry, Jeffrey D Nanson, et al.
Neuron|March 3, 2021
SARM1 is a metabolic sensor activated by an increased NMN/NAD<sup>+</sup> ratio to trigger axon degenerationMatthew D Figley, Weixi Gu, Jeffrey D Nanson, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
JCI Insight|January 4, 2024
Sarm1 knockout prevents type 1 diabetic bone disease in females independent of neuropathyJennifer M Brazill, Ivana R Shen, Clarissa S Craft, et al.
The Journal of Cell Biology|December 22, 2021
Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPNYihang Li, Maria F Pazyra-Murphy, Daina Avizonis, et al.
Clinical Chemistry|February 16, 2017
Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe DiseaseNa Lin, Jingyu Huang, Sara Violante, et al.
Journal of Clinical Immunology|March 1, 2014
Newborn screening for SCID in New York State: experience from the first two yearsBeth H Vogel, Vincent Bonagura, Geoffrey A Weinberg, et al.
Brain : a Journal of Neurology|January 13, 2022
The human cognition-enhancing CORD7 mutation increases active zone number and synaptic releaseMila M Paul, Sven Dannhäuser, Lydia Morris, et al.
The Journal of Biological Chemistry|September 27, 2023
The structure of NAD<sup>+</sup> consuming protein Acinetobacter baumannii TIR domain shows unique kinetics and conformationsErik Klontz, Juliet O Obi, Yajing Wang, et al.
Scientific Reports|March 19, 2016
Clec16a is Critical for Autolysosome Function and Purkinje Cell SurvivalVeronika Redmann, Christopher A Lamb, Seungmin Hwang, et al.
Molecular Neurodegeneration|October 15, 2025
Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapiesEmily L Ward, Larry Benowitz, Thomas M Brunner, et al.
Molecular Cell|March 25, 2022
Structural basis of SARM1 activation, substrate recognition, and inhibition by small moleculesYun Shi, Philip S Kerry, Jeffrey D Nanson, et al.
Neuron|March 3, 2021
SARM1 is a metabolic sensor activated by an increased NMN/NAD<sup>+</sup> ratio to trigger axon degenerationMatthew D Figley, Weixi Gu, Jeffrey D Nanson, et al.
Pageof 18